Singapore markets closed

Heart Test Laboratories, Inc. (HSCS)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
0.0880-0.0019 (-2.11%)
At close: 04:00PM EDT
0.0870 -0.00 (-1.14%)
After hours: 07:16PM EDT

Heart Test Laboratories, Inc.

550 Reserve Street
Suite 360
Southlake, TX 76092
United States
682 237 7781
https://heartsciences.com

Sector(s)Healthcare
IndustryMedical Devices
Full-time employees12

Key executives

NameTitlePayExercisedYear born
Mr. Andrew SimpsonCEO, President & Chairman of the Board of Directors264.14kN/A1970
Ms. Danielle WatsonCFO & Treasurer188.75kN/A1983
Mr. Mark T. HilzCOO, Secretary & Director263.61kN/A1959
Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Heart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals. The company was incorporated in 2007 and is headquartered in Southlake, Texas.

Corporate governance

Heart Test Laboratories, Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.